Myomo posted Q2 2026 revenue of $11.7 million, up 21% year over year; net loss narrowed to $4 million, or $0.09 a share.
Gross margin expanded 9.4 percentage points to 72.1%.
Operating loss narrowed to $2.3 million as operating expenses held at $10.7 million, up less than 1%.
Adjusted EBITDA loss narrowed to $827,282 from $4 million a year earlier; cash, cash equivalents and short-term investments totaled $13.5 million at June 30.
Raised full-year revenue guidance to $45 million-$47 million; sees Q3 revenue of $11.5 million-$12 million, up 14%-19% year over year.
MYO•
